The global market for Chronic Kidney Disease Drugs was valued at US$ 11390 million in the year 2024 and is projected to reach a revised size of US$ 12880 million by 2031, growing at a CAGR of 1.8% during the forecast period.

Chronic Kidney Disease Drugs Market

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Chronic Kidney Disease Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Chronic Kidney Disease Drugs.

The Chronic Kidney Disease Drugs market size, estimations, and forecasts are provided in terms of sales volume (K MT) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Chronic Kidney Disease Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Chronic Kidney Disease Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Chronic Kidney Disease Drugs Market Report

Report Metric	Details
Report Name	Chronic Kidney Disease Drugs Market
Accounted market size in year	US$ 11390 million
Forecasted market size in 2031	US$ 12880 million
CAGR	1.8%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	ACE Inhibitors Calcium Channel Blockers Beta Blockers Others
Segment by Application	Hospitals Specialty Clinics
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Keryx Biopharmaceuticals, Inc, Kissei Pharmaceutical Co., Ltd, AbbVie, GlaxoSmithKline, Sanofi, F. Hoffmann-La Roche Ltd, Pfizer, AstraZeneca, Amgen, Teva Pharmaceutical Industries
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Chronic Kidney Disease Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Chronic Kidney Disease Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Chronic Kidney Disease Drugs Market growing?

Ans: The Chronic Kidney Disease Drugs Market witnessing a CAGR of 1.8% during the forecast period 2025-2031.

What is the Chronic Kidney Disease Drugs Market size in 2031?

Ans: The Chronic Kidney Disease Drugs Market size in 2031 will be US$ 12880 million.

Who are the main players in the Chronic Kidney Disease Drugs Market report?

Ans: The main players in the Chronic Kidney Disease Drugs Market are Keryx Biopharmaceuticals, Inc, Kissei Pharmaceutical Co., Ltd, AbbVie, GlaxoSmithKline, Sanofi, F. Hoffmann-La Roche Ltd, Pfizer, AstraZeneca, Amgen, Teva Pharmaceutical Industries

What are the Application segmentation covered in the Chronic Kidney Disease Drugs Market report?

Ans: The Applications covered in the Chronic Kidney Disease Drugs Market report are Hospitals, Specialty Clinics

What are the Type segmentation covered in the Chronic Kidney Disease Drugs Market report?

Ans: The Types covered in the Chronic Kidney Disease Drugs Market report are ACE Inhibitors, Calcium Channel Blockers, Beta Blockers, Others

1 Chronic Kidney Disease Drugs Market Overview

1.1 Product Definition

1.2 Chronic Kidney Disease Drugs by Type

1.2.1 Global Chronic Kidney Disease Drugs Market Value Comparison by Type (2024 VS 2031)

1.2.2 ACE Inhibitors

1.2.3 Calcium Channel Blockers

1.2.4 Beta Blockers

1.2.5 Others

1.3 Chronic Kidney Disease Drugs by Application

1.3.1 Global Chronic Kidney Disease Drugs Market Value by Application (2024 VS 2031)

1.3.2 Hospitals

1.3.3 Specialty Clinics

1.4 Global Chronic Kidney Disease Drugs Market Size Estimates and Forecasts

1.4.1 Global Chronic Kidney Disease Drugs Revenue 2020-2031

1.4.2 Global Chronic Kidney Disease Drugs Sales 2020-2031

1.4.3 Global Chronic Kidney Disease Drugs Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Chronic Kidney Disease Drugs Market Competition by Manufacturers

2.1 Global Chronic Kidney Disease Drugs Sales Market Share by Manufacturers (2020-2025)

2.2 Global Chronic Kidney Disease Drugs Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Chronic Kidney Disease Drugs Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Chronic Kidney Disease Drugs, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Chronic Kidney Disease Drugs, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Chronic Kidney Disease Drugs, Product Type & Application

2.7 Global Key Manufacturers of Chronic Kidney Disease Drugs, Date of Enter into This Industry

2.8 Global Chronic Kidney Disease Drugs Market Competitive Situation and Trends

2.8.1 Global Chronic Kidney Disease Drugs Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Chronic Kidney Disease Drugs Players Market Share by Revenue

2.8.3 Global Chronic Kidney Disease Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Chronic Kidney Disease Drugs Market Scenario by Region

3.1 Global Chronic Kidney Disease Drugs Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Chronic Kidney Disease Drugs Sales by Region: 2020-2031

3.2.1 Global Chronic Kidney Disease Drugs Sales by Region: 2020-2025

3.2.2 Global Chronic Kidney Disease Drugs Sales by Region: 2026-2031

3.3 Global Chronic Kidney Disease Drugs Revenue by Region: 2020-2031

3.3.1 Global Chronic Kidney Disease Drugs Revenue by Region: 2020-2025

3.3.2 Global Chronic Kidney Disease Drugs Revenue by Region: 2026-2031

3.4 North America Chronic Kidney Disease Drugs Market Facts & Figures by Country

3.4.1 North America Chronic Kidney Disease Drugs Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Chronic Kidney Disease Drugs Sales by Country (2020-2031)

3.4.3 North America Chronic Kidney Disease Drugs Revenue by Country (2020-2031)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Chronic Kidney Disease Drugs Market Facts & Figures by Country

3.5.1 Europe Chronic Kidney Disease Drugs Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Chronic Kidney Disease Drugs Sales by Country (2020-2031)

3.5.3 Europe Chronic Kidney Disease Drugs Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Chronic Kidney Disease Drugs Market Facts & Figures by Region

3.6.1 Asia Pacific Chronic Kidney Disease Drugs Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Chronic Kidney Disease Drugs Sales by Region (2020-2031)

3.6.3 Asia Pacific Chronic Kidney Disease Drugs Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Chronic Kidney Disease Drugs Market Facts & Figures by Country

3.7.1 Latin America Chronic Kidney Disease Drugs Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Chronic Kidney Disease Drugs Sales by Country (2020-2031)

3.7.3 Latin America Chronic Kidney Disease Drugs Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Chronic Kidney Disease Drugs Market Facts & Figures by Country

3.8.1 Middle East and Africa Chronic Kidney Disease Drugs Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Chronic Kidney Disease Drugs Sales by Country (2020-2031)

3.8.3 Middle East and Africa Chronic Kidney Disease Drugs Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 U.A.E

4 Segment by Type

4.1 Global Chronic Kidney Disease Drugs Sales by Type (2020-2031)

4.1.1 Global Chronic Kidney Disease Drugs Sales by Type (2020-2025)

4.1.2 Global Chronic Kidney Disease Drugs Sales by Type (2026-2031)

4.1.3 Global Chronic Kidney Disease Drugs Sales Market Share by Type (2020-2031)

4.2 Global Chronic Kidney Disease Drugs Revenue by Type (2020-2031)

4.2.1 Global Chronic Kidney Disease Drugs Revenue by Type (2020-2025)

4.2.2 Global Chronic Kidney Disease Drugs Revenue by Type (2026-2031)

4.2.3 Global Chronic Kidney Disease Drugs Revenue Market Share by Type (2020-2031)

4.3 Global Chronic Kidney Disease Drugs Price by Type (2020-2031)

5 Segment by Application

5.1 Global Chronic Kidney Disease Drugs Sales by Application (2020-2031)

5.1.1 Global Chronic Kidney Disease Drugs Sales by Application (2020-2025)

5.1.2 Global Chronic Kidney Disease Drugs Sales by Application (2026-2031)

5.1.3 Global Chronic Kidney Disease Drugs Sales Market Share by Application (2020-2031)

5.2 Global Chronic Kidney Disease Drugs Revenue by Application (2020-2031)

5.2.1 Global Chronic Kidney Disease Drugs Revenue by Application (2020-2025)

5.2.2 Global Chronic Kidney Disease Drugs Revenue by Application (2026-2031)

5.2.3 Global Chronic Kidney Disease Drugs Revenue Market Share by Application (2020-2031)

5.3 Global Chronic Kidney Disease Drugs Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Keryx Biopharmaceuticals, Inc

6.1.1 Keryx Biopharmaceuticals, Inc Company Information

6.1.2 Keryx Biopharmaceuticals, Inc Description and Business Overview

6.1.3 Keryx Biopharmaceuticals, Inc Chronic Kidney Disease Drugs Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Keryx Biopharmaceuticals, Inc Chronic Kidney Disease Drugs Product Portfolio

6.1.5 Keryx Biopharmaceuticals, Inc Recent Developments/Updates

6.2 Kissei Pharmaceutical Co., Ltd

6.2.1 Kissei Pharmaceutical Co., Ltd Company Information

6.2.2 Kissei Pharmaceutical Co., Ltd Description and Business Overview

6.2.3 Kissei Pharmaceutical Co., Ltd Chronic Kidney Disease Drugs Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Kissei Pharmaceutical Co., Ltd Chronic Kidney Disease Drugs Product Portfolio

6.2.5 Kissei Pharmaceutical Co., Ltd Recent Developments/Updates

6.3 AbbVie

6.3.1 AbbVie Company Information

6.3.2 AbbVie Description and Business Overview

6.3.3 AbbVie Chronic Kidney Disease Drugs Sales, Revenue and Gross Margin (2020-2025)

6.3.4 AbbVie Chronic Kidney Disease Drugs Product Portfolio

6.3.5 AbbVie Recent Developments/Updates

6.4 GlaxoSmithKline

6.4.1 GlaxoSmithKline Company Information

6.4.2 GlaxoSmithKline Description and Business Overview

6.4.3 GlaxoSmithKline Chronic Kidney Disease Drugs Sales, Revenue and Gross Margin (2020-2025)

6.4.4 GlaxoSmithKline Chronic Kidney Disease Drugs Product Portfolio

6.4.5 GlaxoSmithKline Recent Developments/Updates

6.5 Sanofi

6.5.1 Sanofi Company Information

6.5.2 Sanofi Description and Business Overview

6.5.3 Sanofi Chronic Kidney Disease Drugs Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Sanofi Chronic Kidney Disease Drugs Product Portfolio

6.5.5 Sanofi Recent Developments/Updates

6.6 F. Hoffmann-La Roche Ltd

6.6.1 F. Hoffmann-La Roche Ltd Company Information

6.6.2 F. Hoffmann-La Roche Ltd Description and Business Overview

6.6.3 F. Hoffmann-La Roche Ltd Chronic Kidney Disease Drugs Sales, Revenue and Gross Margin (2020-2025)

6.6.4 F. Hoffmann-La Roche Ltd Chronic Kidney Disease Drugs Product Portfolio

6.6.5 F. Hoffmann-La Roche Ltd Recent Developments/Updates

6.7 Pfizer

6.7.1 Pfizer Company Information

6.7.2 Pfizer Description and Business Overview

6.7.3 Pfizer Chronic Kidney Disease Drugs Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Pfizer Chronic Kidney Disease Drugs Product Portfolio

6.7.5 Pfizer Recent Developments/Updates

6.8 AstraZeneca

6.8.1 AstraZeneca Company Information

6.8.2 AstraZeneca Description and Business Overview

6.8.3 AstraZeneca Chronic Kidney Disease Drugs Sales, Revenue and Gross Margin (2020-2025)

6.8.4 AstraZeneca Chronic Kidney Disease Drugs Product Portfolio

6.8.5 AstraZeneca Recent Developments/Updates

6.9 Amgen

6.9.1 Amgen Company Information

6.9.2 Amgen Description and Business Overview

6.9.3 Amgen Chronic Kidney Disease Drugs Sales, Revenue and Gross Margin (2020-2025)

6.9.4 Amgen Chronic Kidney Disease Drugs Product Portfolio

6.9.5 Amgen Recent Developments/Updates

6.10 Teva Pharmaceutical Industries

6.10.1 Teva Pharmaceutical Industries Company Information

6.10.2 Teva Pharmaceutical Industries Description and Business Overview

6.10.3 Teva Pharmaceutical Industries Chronic Kidney Disease Drugs Sales, Revenue and Gross Margin (2020-2025)

6.10.4 Teva Pharmaceutical Industries Chronic Kidney Disease Drugs Product Portfolio

6.10.5 Teva Pharmaceutical Industries Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Chronic Kidney Disease Drugs Industry Chain Analysis

7.2 Chronic Kidney Disease Drugs Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Chronic Kidney Disease Drugs Production Mode & Process Analysis

7.4 Chronic Kidney Disease Drugs Sales and Marketing

7.4.1 Chronic Kidney Disease Drugs Sales Channels

7.4.2 Chronic Kidney Disease Drugs Distributors

7.5 Chronic Kidney Disease Drugs Customer Analysis

8 Chronic Kidney Disease Drugs Market Dynamics

8.1 Chronic Kidney Disease Drugs Industry Trends

8.2 Chronic Kidney Disease Drugs Market Drivers

8.3 Chronic Kidney Disease Drugs Market Challenges

8.4 Chronic Kidney Disease Drugs Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Keryx Biopharmaceuticals, Inc

Kissei Pharmaceutical Co Ltd

AbbVie

GlaxoSmithKline PLC

Sanofi

F Hoffmann La Roche Ltd

Pfizer Inc

Astrazeneca plc

Amgen Inc

Teva Pharmaceutical Industries

List of Tables

Table 1. Global Chronic Kidney Disease Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Chronic Kidney Disease Drugs Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Chronic Kidney Disease Drugs Market Competitive Situation by Manufacturers in 2024

Table 4. Global Chronic Kidney Disease Drugs Sales (K MT) of Key Manufacturers (2020-2025)

Table 5. Global Chronic Kidney Disease Drugs Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Chronic Kidney Disease Drugs Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Chronic Kidney Disease Drugs Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Chronic Kidney Disease Drugs Average Price (USD/MT) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Chronic Kidney Disease Drugs, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Chronic Kidney Disease Drugs, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Chronic Kidney Disease Drugs, Product Type & Application

Table 12. Global Key Manufacturers of Chronic Kidney Disease Drugs, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Chronic Kidney Disease Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chronic Kidney Disease Drugs as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Chronic Kidney Disease Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Chronic Kidney Disease Drugs Sales by Region (2020-2025) & (K MT)

Table 18. Global Chronic Kidney Disease Drugs Sales Market Share by Region (2020-2025)

Table 19. Global Chronic Kidney Disease Drugs Sales by Region (2026-2031) & (K MT)

Table 20. Global Chronic Kidney Disease Drugs Sales Market Share by Region (2026-2031)

Table 21. Global Chronic Kidney Disease Drugs Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Chronic Kidney Disease Drugs Revenue Market Share by Region (2020-2025)

Table 23. Global Chronic Kidney Disease Drugs Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Chronic Kidney Disease Drugs Revenue Market Share by Region (2026-2031)

Table 25. North America Chronic Kidney Disease Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Chronic Kidney Disease Drugs Sales by Country (2020-2025) & (K MT)

Table 27. North America Chronic Kidney Disease Drugs Sales by Country (2026-2031) & (K MT)

Table 28. North America Chronic Kidney Disease Drugs Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Chronic Kidney Disease Drugs Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Chronic Kidney Disease Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Chronic Kidney Disease Drugs Sales by Country (2020-2025) & (K MT)

Table 32. Europe Chronic Kidney Disease Drugs Sales by Country (2026-2031) & (K MT)

Table 33. Europe Chronic Kidney Disease Drugs Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Chronic Kidney Disease Drugs Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Chronic Kidney Disease Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Chronic Kidney Disease Drugs Sales by Region (2020-2025) & (K MT)

Table 37. Asia Pacific Chronic Kidney Disease Drugs Sales by Region (2026-2031) & (K MT)

Table 38. Asia Pacific Chronic Kidney Disease Drugs Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Chronic Kidney Disease Drugs Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Chronic Kidney Disease Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Chronic Kidney Disease Drugs Sales by Country (2020-2025) & (K MT)

Table 42. Latin America Chronic Kidney Disease Drugs Sales by Country (2026-2031) & (K MT)

Table 43. Latin America Chronic Kidney Disease Drugs Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Chronic Kidney Disease Drugs Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Chronic Kidney Disease Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Chronic Kidney Disease Drugs Sales by Country (2020-2025) & (K MT)

Table 47. Middle East and Africa Chronic Kidney Disease Drugs Sales by Country (2026-2031) & (K MT)

Table 48. Middle East and Africa Chronic Kidney Disease Drugs Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Chronic Kidney Disease Drugs Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Chronic Kidney Disease Drugs Sales (K MT) by Type (2020-2025)

Table 51. Global Chronic Kidney Disease Drugs Sales (K MT) by Type (2026-2031)

Table 52. Global Chronic Kidney Disease Drugs Sales Market Share by Type (2020-2025)

Table 53. Global Chronic Kidney Disease Drugs Sales Market Share by Type (2026-2031)

Table 54. Global Chronic Kidney Disease Drugs Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Chronic Kidney Disease Drugs Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Chronic Kidney Disease Drugs Revenue Market Share by Type (2020-2025)

Table 57. Global Chronic Kidney Disease Drugs Revenue Market Share by Type (2026-2031)

Table 58. Global Chronic Kidney Disease Drugs Price (USD/MT) by Type (2020-2025)

Table 59. Global Chronic Kidney Disease Drugs Price (USD/MT) by Type (2026-2031)

Table 60. Global Chronic Kidney Disease Drugs Sales (K MT) by Application (2020-2025)

Table 61. Global Chronic Kidney Disease Drugs Sales (K MT) by Application (2026-2031)

Table 62. Global Chronic Kidney Disease Drugs Sales Market Share by Application (2020-2025)

Table 63. Global Chronic Kidney Disease Drugs Sales Market Share by Application (2026-2031)

Table 64. Global Chronic Kidney Disease Drugs Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Chronic Kidney Disease Drugs Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Chronic Kidney Disease Drugs Revenue Market Share by Application (2020-2025)

Table 67. Global Chronic Kidney Disease Drugs Revenue Market Share by Application (2026-2031)

Table 68. Global Chronic Kidney Disease Drugs Price (USD/MT) by Application (2020-2025)

Table 69. Global Chronic Kidney Disease Drugs Price (USD/MT) by Application (2026-2031)

Table 70. Keryx Biopharmaceuticals, Inc Company Information

Table 71. Keryx Biopharmaceuticals, Inc Description and Business Overview

Table 72. Keryx Biopharmaceuticals, Inc Chronic Kidney Disease Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 73. Keryx Biopharmaceuticals, Inc Chronic Kidney Disease Drugs Product

Table 74. Keryx Biopharmaceuticals, Inc Recent Developments/Updates

Table 75. Kissei Pharmaceutical Co., Ltd Company Information

Table 76. Kissei Pharmaceutical Co., Ltd Description and Business Overview

Table 77. Kissei Pharmaceutical Co., Ltd Chronic Kidney Disease Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 78. Kissei Pharmaceutical Co., Ltd Chronic Kidney Disease Drugs Product

Table 79. Kissei Pharmaceutical Co., Ltd Recent Developments/Updates

Table 80. AbbVie Company Information

Table 81. AbbVie Description and Business Overview

Table 82. AbbVie Chronic Kidney Disease Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 83. AbbVie Chronic Kidney Disease Drugs Product

Table 84. AbbVie Recent Developments/Updates

Table 85. GlaxoSmithKline Company Information

Table 86. GlaxoSmithKline Description and Business Overview

Table 87. GlaxoSmithKline Chronic Kidney Disease Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 88. GlaxoSmithKline Chronic Kidney Disease Drugs Product

Table 89. GlaxoSmithKline Recent Developments/Updates

Table 90. Sanofi Company Information

Table 91. Sanofi Description and Business Overview

Table 92. Sanofi Chronic Kidney Disease Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 93. Sanofi Chronic Kidney Disease Drugs Product

Table 94. Sanofi Recent Developments/Updates

Table 95. F. Hoffmann-La Roche Ltd Company Information

Table 96. F. Hoffmann-La Roche Ltd Description and Business Overview

Table 97. F. Hoffmann-La Roche Ltd Chronic Kidney Disease Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 98. F. Hoffmann-La Roche Ltd Chronic Kidney Disease Drugs Product

Table 99. F. Hoffmann-La Roche Ltd Recent Developments/Updates

Table 100. Pfizer Company Information

Table 101. Pfizer Description and Business Overview

Table 102. Pfizer Chronic Kidney Disease Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 103. Pfizer Chronic Kidney Disease Drugs Product

Table 104. Pfizer Recent Developments/Updates

Table 105. AstraZeneca Company Information

Table 106. AstraZeneca Description and Business Overview

Table 107. AstraZeneca Chronic Kidney Disease Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 108. AstraZeneca Chronic Kidney Disease Drugs Product

Table 109. AstraZeneca Recent Developments/Updates

Table 110. Amgen Company Information

Table 111. Amgen Description and Business Overview

Table 112. Amgen Chronic Kidney Disease Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 113. Amgen Chronic Kidney Disease Drugs Product

Table 114. Amgen Recent Developments/Updates

Table 115. Teva Pharmaceutical Industries Company Information

Table 116. Teva Pharmaceutical Industries Description and Business Overview

Table 117. Teva Pharmaceutical Industries Chronic Kidney Disease Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 118. Teva Pharmaceutical Industries Chronic Kidney Disease Drugs Product

Table 119. Teva Pharmaceutical Industries Recent Developments/Updates

Table 120. Key Raw Materials Lists

Table 121. Raw Materials Key Suppliers Lists

Table 122. Chronic Kidney Disease Drugs Distributors List

Table 123. Chronic Kidney Disease Drugs Customers List

Table 124. Chronic Kidney Disease Drugs Market Trends

Table 125. Chronic Kidney Disease Drugs Market Drivers

Table 126. Chronic Kidney Disease Drugs Market Challenges

Table 127. Chronic Kidney Disease Drugs Market Restraints

Table 128. Research Programs/Design for This Report

Table 129. Key Data Information from Secondary Sources

Table 130. Key Data Information from Primary Sources

Table 131. Authors List of This Report

List of Figures

Figure 1. Product Picture of Chronic Kidney Disease Drugs

Figure 2. Global Chronic Kidney Disease Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Chronic Kidney Disease Drugs Market Share by Type: 2024 & 2031

Figure 4. ACE Inhibitors Product Picture

Figure 5. Calcium Channel Blockers Product Picture

Figure 6. Beta Blockers Product Picture

Figure 7. Others Product Picture

Figure 8. Global Chronic Kidney Disease Drugs Market Value by Application (2020-2031) & (US$ Million)

Figure 9. Global Chronic Kidney Disease Drugs Market Share by Application: 2024 & 2031

Figure 10. Hospitals

Figure 11. Specialty Clinics

Figure 12. Global Chronic Kidney Disease Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 13. Global Chronic Kidney Disease Drugs Market Size (2020-2031) & (US$ Million)

Figure 14. Global Chronic Kidney Disease Drugs Sales (2020-2031) & (K MT)

Figure 15. Global Chronic Kidney Disease Drugs Average Price (USD/MT) & (2020-2031)

Figure 16. Chronic Kidney Disease Drugs Report Years Considered

Figure 17. Chronic Kidney Disease Drugs Sales Share by Manufacturers in 2024

Figure 18. Global Chronic Kidney Disease Drugs Revenue Share by Manufacturers in 2024

Figure 19. Global 5 and 10 Largest Chronic Kidney Disease Drugs Players: Market Share by Revenue in Chronic Kidney Disease Drugs in 2024

Figure 20. Chronic Kidney Disease Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 21. Global Chronic Kidney Disease Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 22. North America Chronic Kidney Disease Drugs Sales Market Share by Country (2020-2031)

Figure 23. North America Chronic Kidney Disease Drugs Revenue Market Share by Country (2020-2031)

Figure 24. U.S. Chronic Kidney Disease Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 25. Canada Chronic Kidney Disease Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 26. Europe Chronic Kidney Disease Drugs Sales Market Share by Country (2020-2031)

Figure 27. Europe Chronic Kidney Disease Drugs Revenue Market Share by Country (2020-2031)

Figure 28. Germany Chronic Kidney Disease Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. France Chronic Kidney Disease Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. U.K. Chronic Kidney Disease Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Italy Chronic Kidney Disease Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Russia Chronic Kidney Disease Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 33. Asia Pacific Chronic Kidney Disease Drugs Sales Market Share by Region (2020-2031)

Figure 34. Asia Pacific Chronic Kidney Disease Drugs Revenue Market Share by Region (2020-2031)

Figure 35. China Chronic Kidney Disease Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. Japan Chronic Kidney Disease Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. South Korea Chronic Kidney Disease Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. India Chronic Kidney Disease Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. Australia Chronic Kidney Disease Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Taiwan Chronic Kidney Disease Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Indonesia Chronic Kidney Disease Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Thailand Chronic Kidney Disease Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Malaysia Chronic Kidney Disease Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Philippines Chronic Kidney Disease Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Latin America Chronic Kidney Disease Drugs Sales Market Share by Country (2020-2031)

Figure 46. Latin America Chronic Kidney Disease Drugs Revenue Market Share by Country (2020-2031)

Figure 47. Mexico Chronic Kidney Disease Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. Brazil Chronic Kidney Disease Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 49. Argentina Chronic Kidney Disease Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 50. Middle East and Africa Chronic Kidney Disease Drugs Sales Market Share by Country (2020-2031)

Figure 51. Middle East and Africa Chronic Kidney Disease Drugs Revenue Market Share by Country (2020-2031)

Figure 52. Turkey Chronic Kidney Disease Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 53. Saudi Arabia Chronic Kidney Disease Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 54. U.A.E Chronic Kidney Disease Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 55. Global Sales Market Share of Chronic Kidney Disease Drugs by Type (2020-2031)

Figure 56. Global Revenue Market Share of Chronic Kidney Disease Drugs by Type (2020-2031)

Figure 57. Global Chronic Kidney Disease Drugs Price (USD/MT) by Type (2020-2031)

Figure 58. Global Sales Market Share of Chronic Kidney Disease Drugs by Application (2020-2031)

Figure 59. Global Revenue Market Share of Chronic Kidney Disease Drugs by Application (2020-2031)

Figure 60. Global Chronic Kidney Disease Drugs Price (USD/MT) by Application (2020-2031)

Figure 61. Chronic Kidney Disease Drugs Value Chain

Figure 62. Channels of Distribution (Direct Vs Distribution)

Figure 63. Bottom-up and Top-down Approaches for This Report

Figure 64. Data Triangulation

Figure 65. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Kidney Disease Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Still s Disease Treatment Market Research Report 2025

Global Renal Disease Treatment Market Research Report 2024

Global Treatment Planning Software Market Research Report 2025

Global Pharmaceutical Asset Management Market Research Report 2025

Global Continuous Renal Replacement Therapy Market Research Report 2024

Global Cardiovascular Disease Nursing Drugs Market Research Report 2025

Global Pharmerging Market Research Report 2025

Global Combination Therapy Drug Market Research Report 2025

Global Pharmaceutical Validation Services Market Research Report 2025

Global CGT Drugs Market Research Report 2025

Global Medicines for Alzheimer Disease Treatment Market Research Report 2025

Chronic Metabolic Disease Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Pharmaceutical Filter Aid Market Research Report 2025

Global Drug Safety and Pharmacovigilance Service Market Research Report 2025

Global Weekly Pill Organizer Market Research Report 2025

Global Diagnostic Guidewire Market Research Report 2024

Global Pharma Contract Service Market Research Report 2025

Global Coding and Marking for Pharmaceuticals and Consumer Products Market Research Report 2024

RELATED REPORTS

Global 2-(4-Fluorophenyl)thiophene Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-3W15203

Wed Apr 23 00:00:00 UTC 2025

Add to Cart

Global Circulating Tumor Cells Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

120 Pages

Type: Report

Code: QYRE-Auto-37Y9103

Wed Apr 23 00:00:00 UTC 2025

Add to Cart

Global Cardiovascular Disease Diagnosis Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-33N19169

Wed Apr 23 00:00:00 UTC 2025

Add to Cart

Global Cancer Treatment Drugs Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

120 Pages

Type: Report

Code: QYRE-Auto-4I9425

Wed Apr 23 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

[email protected]

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

	
		OSZAR »